Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.
Press releases published on May 8, 2025

Deckhouse Communications and iO3 Collaborate to Bring Advanced Digital Solutions to Turkish Maritime Sector
SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iO3" or the "Company") (NASDAQ: IOTR), a pioneering provider of digital solutions for the maritime industry, is pleased to announce a strategic collaboration with Deckhouse Communications, a …

ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R…

MicroAlgo Inc. Develops a Blockchain Storage Optimization Solution Based on the Archimedes Optimization Algorithm (AOA)
SHENZHEN, May 08, 2025 (GLOBE NEWSWIRE) -- MicroAlgo Inc. Develops a Blockchain Storage Optimization Solution Based on the Archimedes Optimization Algorithm (AOA) Shenzhen, May. 08, 2025/––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), …

Primech AI Plans Production of 300 HYTRON Robots through its China Manufacturing Expansion
SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. ("Primech AI" or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced a significant expansion of its manufacturing capabilities through a strategic …

Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to treating the core symptoms of autism spectrum disorder (ASD), today announced positive Phase 2 results for L1-79, presented at the …

Studio City International Holdings Limited Announces Unaudited First Quarter 2025 Earnings
MACAU, May 08, 2025 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the first quarter …

Melco Announces Unaudited First Quarter 2025 Earnings
MACAU, May 08, 2025 (GLOBE NEWSWIRE) -- Melco Resorts …

BitFuFu Announces April 2025 Bitcoin Mining and Operation Updates
Total hashrate under management reached 28.3 EH/s as of April 30, 2025, a 37.4% month-over-month increase. Total power capacity under management rose to 566 MW across five continents as of April 30, 2025, an 18.4% month-over-month increase. Bitcoin …

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …

ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …

Cue Biopharma to Host Virtual Investor Event on May 15, 2025
Mobilizing the Immune System: Cue Biopharma's Novel Biologics Portfolio Event Virtual Event will Feature Key Opinion Leaders Richard DiPaolo, PhD, and Andrew Cope, MD, PhD BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a …

Xunlei Limited Schedules 2025 Unaudited First Quarter Earnings Release on May 15, 2025
SHENZHEN, China, May 08, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial …

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …

Pasinex Announces Issuance of Failure to File Cease Trade Order
TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced that the British Columbia Securities Commission, as its principal regulator, has issued a Failure to File Cease Trade …

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …

American Tungsten Corp. Announces Addition to Board of Directors
Vancouver, BC, May 08, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces today the appointment of James (Jim) Whittaker to the Board of Directors of the Company (the “Board …

Dada to Hold Extraordinary General Meeting of Shareholders
SHANGHAI, China, May 08, 2025 (GLOBE NEWSWIRE) -- Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that it has called an extraordinary general meeting of shareholders …

Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, May 15, …

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activities and …